Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Each case is unique and past results do not guarantee future outcomes
Liraglutide The injectable GLP-1 analogue, liraglutide (Victoza), is FDA approved for once-daily subcutaneous administration in combination with diet and exercise for the treatment of patients with T2DM
GLP-1 receptor (GLP-1R) agonists have shown neuroprotective effects in preclinical and clinical studies on neurodegenerative diseases in both the brain (e.g., Alzheimers disease, Parkinsons disease, stroke and diabetic neuropathy) and the eye (e.g., diabetic retinopathy and AMD)
Key finding: Six months of supplementation significantly increased glutathione in blood, erythrocytes, plasma, and buccal cells at both 250mg and 1,000mg/day
It is vegan, non-GMO, and produced in a GMP-certified facility to support digestive health, gentle detox, and metabolic function
Some people find certain foods consistently worsen their symptoms
